Antiarrhythmic agents: modulated receptor applications.
1987; Lippincott Williams & Wilkins; Volume: 75; Issue: 3 Linguagem: Inglês
10.1161/01.cir.75.3.514
ISSN1524-4539
Autores Tópico(s)Electrochemical Analysis and Applications
ResumoHomeCirculationVol. 75, No. 3Antiarrhythmic agents: modulated receptor applications. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBAntiarrhythmic agents: modulated receptor applications. L M Hondeghem L M HondeghemL M Hondeghem Originally published1 Mar 1987https://doi.org/10.1161/01.CIR.75.3.514Circulation. 1987;75:514–520 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Hesketh L, Sikkel M, Mahoney‐Sanchez L, Mazzacuva F, Chowdhury R, Tzortzis K, Firth J, Winter J, MacLeod K, Ogrodzinski S, Wilder C, Patterson L, Peters N and Curtis M (2022) OCT2013, an ischaemia‐activated antiarrhythmic prodrug, devoid of the systemic side effects of lidocaine, British Journal of Pharmacology, 10.1111/bph.15764, 179:9, (2037-2053), Online publication date: 1-May-2022. Premont A, Balthes S, Marr C and Jeevaratnam K (2021) Fundamentals of arrhythmogenic mechanisms and treatment strategies for equine atrial fibrillation, Equine Veterinary Journal, 10.1111/evj.13518, 54:2, (262-282), Online publication date: 1-Mar-2022. Uzelac I, Kaboudian A, Iravanian S, Siles-Paredes J, Gumbart J, Ashikaga H, Bhatia N, Gilmour R, Cherry E and Fenton F (2021) Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations, Heart Rhythm O2, 10.1016/j.hroo.2021.06.008, 2:4, (394-404), Online publication date: 1-Aug-2021. Hesketh L, Wilder C, Ranadive N, Lytra G, Qazimi P, Munro J, Ahdi N and Curtis M (2020) Characterisation of mexiletine's translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart, Scientific Reports, 10.1038/s41598-020-65190-y, 10:1, Online publication date: 1-Dec-2020. Walker M, Hayes E, Saint D, Adaikan G, Abraham S, Goldin A, Beatch G, MacLeod B, Wall R and Pugsley M (2018) Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2018.06.157, 106, (510-522), Online publication date: 1-Oct-2018. Carstensen H, Hesselkilde E, Fenner M, Loft-Andersen A, Flethøj M, Kanters J, Sattler S, Tfelt-Hansen J, Pehrson S, Jespersen T and Buhl R (2018) Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses, Journal of Veterinary Internal Medicine, 10.1111/jvim.15287, 32:5, (1708-1717), Online publication date: 1-Sep-2018. Bergenholm L, Parkinson J, Mettetal J, Evans N, Chappell M and Collins T (2017) Predicting QRS and PR interval prolongations in humans using nonclinical data, British Journal of Pharmacology, 10.1111/bph.13940, 174:19, (3268-3283), Online publication date: 1-Oct-2017. Osadchii O (2017) Role of abnormal repolarization in the mechanism of cardiac arrhythmia, Acta Physiologica, 10.1111/apha.12902, 220, (1-71), Online publication date: 1-Jul-2017. Kaplan D, Isom L and Petrou S (2016) Role of Sodium Channels in Epilepsy, Cold Spring Harbor Perspectives in Medicine, 10.1101/cshperspect.a022814, 6:6, (a022814), Online publication date: 1-Jun-2016. Pugsley M, Saint D, Hayes E, Abraham S and Walker M (2015) An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist, European Journal of Pharmacology, 10.1016/j.ejphar.2015.06.018, 761, (330-340), Online publication date: 1-Aug-2015. Priori S, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott P, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck K, Hernandez-Madrid A, Nikolaou N, Norekvål T, Spaulding C and Van Veldhuisen D (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, European Heart Journal, 10.1093/eurheartj/ehv316, 36:41, (2793-2867), Online publication date: 1-Nov-2015. Curtis M, Hancox J, Farkas A, Wainwright C, Stables C, Saint D, Clements-Jewery H, Lambiase P, Billman G, Janse M, Pugsley M, Ng G, Roden D, Camm A and Walker M (2013) The Lambeth Conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2013.04.008, 139:2, (213-248), Online publication date: 1-Aug-2013. Mahajan A and Hogue C (2013) Antiarrhythmic drugs Anesthetic Pharmacology, 10.1017/CBO9780511781933.044, (689-705) Osadchii O (2012) Impact of Na+ channel blockers on transmural dispersion of refractoriness and arrhythmic susceptibility in guinea-pig left ventricle, European Journal of Pharmacology, 10.1016/j.ejphar.2012.07.015, 691:1-3, (173-181), Online publication date: 1-Sep-2012. Subbiah R and Campbell T (2011) Antiarrhythmic drugs Coronary Care Manual, 10.1016/B978-0-7295-3927-2.10030-2, (224-241), . Hondeghem L (2011) QT Prolongation Is a Poor Predictor of Proarrhythmia Liability: Beyond QT Prolongation! Heart Rate and Rhythm, 10.1007/978-3-642-17575-6_36, (639-654), . Lieu P, Fornari M, Ramos T, Hatcher A and Clements-Jewery H (2011) Reduced Antiarrhythmic Efficacy of Verapamil in Isolated Rat Hearts in the Presence of Elevated Extracellular Calcium, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0b013e31820ff60e, 57:4, (455-462), Online publication date: 1-Apr-2011. Charbit B, Gayat E, Voiriot P, Boccara F, Girard P and Funck-Brentano C (2011) Effects of HIV Protease Inhibitors on Cardiac Conduction Velocity in Unselected HIV-Infected Patients, Clinical Pharmacology & Therapeutics, 10.1038/clpt.2011.131, 90:3, (442-448), Online publication date: 1-Sep-2011. Clements‐Jewery H and Curtis M (2009) Selective Targeting of Ventricular Potassium Channels for Arrhythmia Suppression: Feasible or Risible? Novel Therapeutic Targets for Antiarrhythmic Drugs, 10.1002/9780470561416.ch13, (367-379), Online publication date: 16-Dec-2009. Lagrutta A and Salata J (2009) Safety Pharmacology and Regulatory Issues in the Development of Antiarrhythmic Medications Novel Therapeutic Targets for Antiarrhythmic Drugs, 10.1002/9780470561416.ch8, (233-269), Online publication date: 16-Dec-2009. Billman G (2008) The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2008.07.004, 120:1, (54-70), Online publication date: 1-Oct-2008. Hondeghem L (2008) Use and abuse of QT and TRIaD in cardiac safety research: Importance of study design and conduct, European Journal of Pharmacology, 10.1016/j.ejphar.2008.01.016, 584:1, (1-9), Online publication date: 1-Apr-2008. Walker M and So P (2007) Antiarrhythmics Comprehensive Medicinal Chemistry II, 10.1016/B0-08-045044-X/00195-4, (729-762), . Roden D, Darbar D and Kannankeril P (2007) Antiarrhythmic Drugs Cardiovascular Medicine, 10.1007/978-1-84628-715-2_102, (2085-2102), . Zipes D, Camm A, Borggrefe M, Buxton A, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss A, Myerburg R, Priori S, Quinones M, Roden D, Silka M and Tracy C (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Circulation, 114:10, (e385-e484), Online publication date: 5-Sep-2006. Darbar D and Roden D (2006) Future of antiarrhythmic drugs, Current Opinion in Cardiology, 10.1097/01.hco.0000231407.61683.05, 21:4, (361-367), Online publication date: 1-Jul-2006. Clements-Jewery H, Kanaganayagam G, Kabra R and Curtis M (2009) Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts, British Journal of Pharmacology, 10.1038/sj.bjp.0706633, 147:5, (468-475), Online publication date: 1-Mar-2006. Walker M (2009) Antiarrhythmic drug research, British Journal of Pharmacology, 10.1038/sj.bjp.0706500, 147:S1, (S222-S231), Online publication date: 1-Jan-2006. Zipes D, Camm A, Borggrefe M, Buxton A, Chaitman B, Fromer M, Gregoratos G, Klein G, Myerburg R, Quinones M, Roden D, Silka M, Tracy C, Smith S, Jacobs A, Adams C, Antman E, Anderson J, Hunt S, Halperin J, Nishimura R, Ornato J, Page R, Riegel B, Priori S, Moss A, Priori S, Blanc J, Budaj A, Camm A, Dean V, Deckers J, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J and Zamorano J (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Journal of the American College of Cardiology, 10.1016/j.jacc.2006.07.010, 48:5, (e247-e346), Online publication date: 1-Sep-2006. Chiang C, Wang T and Luk H (2004) Inhibition of L-type Ca2+ current in guinea pig ventricular myocytes by cisapride, Journal of Biomedical Science, 10.1007/BF02254434, 11:3, (303-314), Online publication date: 1-May-2004. Coumel P, Maison-Blanche P, Tarral E, Périer A, Milliez P and Leenhardt A (2003) Pharmacodynamic Equivalence of Two Flecainide Acetate Formulations in Patients With Paroxysmal Atrial Fibrillation by QRS Analysis of Ambulatory Electrocardiogram, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200305000-00015, 41:5, (771-779), Online publication date: 1-May-2003. HONDEGHEM L, LU H, ROSSEM K and De CLERCK F (2003) Detection of Proarrhythmia in the Female Rabbit Heart:, Journal of Cardiovascular Electrophysiology, 10.1046/j.1540-8167.2003.02466.x, 14:3, (287-294), Online publication date: 1-Mar-2003. Lee K, Park J, Jeon B, Kim K, Ryu P, Kwon L and Kim H (2003) Differential Recovery of Action Potential Duration and HERG Currents from the Effects of Two Methanesulfonamide Class III Antiarrhythmic Agents, KCB-328 and Dofetilide, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200311000-00011, 42:5, (648-655), Online publication date: 1-Nov-2003. Pugsley M (2002) Antiarrhythmic drug development: Historical review and future perspective, Drug Development Research, 10.1002/ddr.10036, 55:1, (3-16), Online publication date: 1-Jan-2002. Zhang Y and Hancox J (2002) Mode-dependent inhibition by quinidine of Na+-Ca2+ exchanger current from guinea-pig isolated ventricular myocytes, Clinical and Experimental Pharmacology and Physiology, 10.1046/j.1440-1681.2002.03731.x, 29:9, (777-781), Online publication date: 1-Sep-2002. Schiraldi F, Ferraro P and Paladino F (2001) Physiologic Imbalance as a Cause of Cardiac Arrhythmias Critical Care Cardiology in the Perioperative Period, 10.1007/978-88-470-2955-2_8, (101-114), . Schiraldi F, Ferraro P and Maglione B (2000) Heart and Electrolytes Anesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E., 10.1007/978-88-470-2286-7_36, (317-324), . Kowey P, Marinchak R, Rials S and Bharucha D (2000) Classification and pharmacology of antiarrhythmic drugs, American Heart Journal, 10.1067/mhj.2000.106640, 140:1, (12-20), Online publication date: 1-Jul-2000. (2000) Synthesis of the Cardiac Purkinje-fiber Action Potential Using a Computer Model An Introduction to Cardiac Electrophysiology, 10.3109/9780203303887-11, (209-226) Badicu N, Loloiu T, Gavriliu D, Loloiu G and Maior O (1999) Synthesis of n-(phenoxathiin-2-carbonyl)-or N-(thianthrene-2-carbonyl)-N′-arylthioureas, Chemistry of Heterocyclic Compounds, 10.1007/BF02251824, 35:12, (1474-1479), Online publication date: 1-Dec-1999. Roden D (1998) Mechanisms and management of proarrhythmia, The American Journal of Cardiology, 10.1016/S0002-9149(98)00472-X, 82:4, (49I-57I), Online publication date: 1-Aug-1998. Supuran C, Scozzafava A, Briganti F, Loloiu G and Maior O (2009) Sulfonylamido Derivatives of 2-Aminophenoxathiin-10,10-Dioxide and Related Compounds Possess Antifungal Action Due to the Possible Inhibition of Lanosterol-14-α-Demethylase, Journal of Enzyme Inhibition, 10.3109/14756369809021477, 13:4, (291-310), Online publication date: 1-Jan-1998. Wood A, Grace A and Camm A (1998) Quinidine, New England Journal of Medicine, 10.1056/NEJM199801013380107, 338:1, (35-45), Online publication date: 1-Jan-1998. Supuran C, Scozzafava A, Briganti F, Loloiu G and Maior O (1998) The antifungal activity of sulfonylamido derivatives of 2-aminophenoxathiin and related compounds, European Journal of Medicinal Chemistry, 10.1016/S0223-5234(99)80034-8, 33:10, (821-830), Online publication date: 1-Oct-1998. Weiss J (1997) Ion Channels in Cardiac Muscle The Myocardium, 10.1016/B978-012436570-4/50005-4, (81-142), . Pérez O, Valenzuela C, Delpón E and Tamargo J (2009) Electrophysiological effects of CI-980, a tubulin binding agent, on guinea-pig papillary muscles, British Journal of Pharmacology, 10.1038/sj.bjp.0700878, 120:2, (187-192), Online publication date: 1-Jan-1997. GRANT A (1997) Mechanisms of Action of Antiarrhythmic Drugs: From Ion Channel Blockage to Arrhythmia Termination, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1997.tb06202.x, 20:2, (432-444), Online publication date: 1-Feb-1997. Yang Q, Padrini R, Bova S, Piovan D and Magnolfi G (2012) Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart, British Journal of Pharmacology, 10.1111/j.1476-5381.1995.tb14966.x, 114:8, (1745-1749), Online publication date: 1-Apr-1995. Pugsley M, Saint D, Hayes E, Berlin K and Walker M (1995) The cardiac electrophysiological effects of sparteine and its analogue BRB-I-28 in the rat, European Journal of Pharmacology, 10.1016/0014-2999(95)00551-X, 294:1, (319-327), Online publication date: 1-Dec-1995. Barrett T, Hayes E and Walker M (1995) Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias, European Journal of Pharmacology, 10.1016/0014-2999(95)00406-B, 285:3, (229-238), Online publication date: 1-Oct-1995. Villemaire C and Nattel S (1994) Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis., Circulation, 89:6, (2870-2878), Online publication date: 1-Jun-1994.Lai W, Lee C and Wu S (1994) Rate-dependent properties of adenosine-induced negative dromotropism in humans., Circulation, 90:4, (1832-1839), Online publication date: 1-Oct-1994. Su M, Chang Y, Chi J and Lee S (1994) Thaliporphine, a positive inotropic agent with a negative chronotropic action, European Journal of Pharmacology, 10.1016/0014-2999(94)90381-6, 254:1-2, (141-150), Online publication date: 1-Mar-1994. Sadanaga T and Ogawa S (1994) Ischemia enhances use-Dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agent, Journal of the American College of Cardiology, 10.1016/0735-1097(94)90380-8, 23:6, (1378-1381), Online publication date: 1-May-1994. HONDEGHEM L (1994) Computer Aided Development of Antiarrhythmic Agents with Class III a Properties , Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.1994.tb01193.x, 5:8, (711-721), Online publication date: 1-Aug-1994. Scholz H (1994) Classification and mechanism of action of antiarrhythmic drugs, Fundamental & Clinical Pharmacology, 10.1111/j.1472-8206.1994.tb00817.x, 8:5, (385-390), Online publication date: 10-Sep-1994. FRANZ M (1994) Bridging the Gap Between Basic and Clinical Electrophysiology:., Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.1994.tb01192.x, 5:8, (699-710), Online publication date: 1-Aug-1994. Katritsis D and John CAMM A (1994) Antiarrhythmic drug classifications and the clinician: A gambit in the land of chaos, Clinical Cardiology, 10.1002/clc.4960170307, 17:3, (142-148), Online publication date: 1-Mar-1994. TAKANAKA C, LEE J, NONOKAWA M, SUGIYAMA T and YAME S (1994) Frequency Dependent Effects of Class I Antiarrhythmic Agents Studied in Patients with Implanted Pacemakers, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1994.tb03808.x, 17:11, (2100-2105), Online publication date: 1-Nov-1994. Twidale N, Roberts-Thomson P, McRitchie R and Chalmers J (1994) COMPARATIVE HAEMODYNAMIC EFFECTS OF VERAPAMIL, FLECAINIDE, AMIODARONE AND SOTALOL IN THE CONSCIOUS RABBIT, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.1994.tb02493.x, 21:3, (179-188), Online publication date: 1-Mar-1994. Sadanaga T, Ogawa S, Okada Y, Tsutsumi N, Iwanaga S, Yoshikawa T, Akaishi M and Handa S (1993) Clinical evaluation of the use-dependent QRS prolongation and the reverse use-dependent QT prolongation of class I and class III antiarrhythmic agents and their value in predicting efficacy, American Heart Journal, 10.1016/S0002-8703(07)80017-2, 126:1, (114-121), Online publication date: 1-Jul-1993. Roden D (1993) Clinical Pharmacodynamics of Cardiovascular Agents: Focus on Sudden Cardiac Death Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development, 10.1007/978-1-4757-1520-0_22, (207-215), . Pastor A, Almendral J, Arenal A, Teresa Lorca M and Delcán J (1993) Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease, The American Journal of Cardiology, 10.1016/0002-9149(93)90185-F, 72:18, (1389-1394), Online publication date: 1-Dec-1993. Funck-Brentano C (1993) Rate-dependence of class III actions in the heart, Fundamental & Clinical Pharmacology, 10.1111/j.1472-8206.1993.tb00217.x, 7:1, (51-59), Online publication date: 1-Feb-1993. Wyse K, Ye V and Campbell T (2012) Effects of hyperkalaemia on the depression of maximum rate of depolarization by class I antiarrhythmic agents in guinea-pig myocardium, British Journal of Pharmacology, 10.1111/j.1476-5381.1993.tb13471.x, 108:1, (255-261), Online publication date: 1-Jan-1993. Villemaire C, Savard P, Talajic M and Nattel S (1992) A quantitative analysis of use-dependent ventricular conduction slowing by procainamide in anesthetized dogs., Circulation, 85:6, (2255-2266), Online publication date: 1-Jun-1992.Talajic M, Lemery R, Roy D, Villemaire C, Cartier R, Coutu B and Nattel S (1992) Rate-dependent effects of diltiazem on human atrioventricular nodal properties., Circulation, 86:3, (870-877), Online publication date: 1-Sep-1992. Delpón E, Valenzuela C, Pérez O, Statkow P, Aguirre D, Cillero J and Tamargo J (1992) Pharmacology of CRE-1087, A New Antiarrhythmic Drug, Cardiovascular Drug Reviews, 10.1111/j.1527-3466.1992.tb00253.x, 10:3, (307-322), Online publication date: 1-Sep-1992. Franz M and Koller B (1992) The Contribution of Monophasic Action Potential Recordings to the Understanding of Atrial Fibrillation Cardiac Arrhythmias: The Management of Atrial Fibrillation, 10.1007/978-3-662-30492-1_3, (27-38), . GREENSPON A, KIDWELL G, DeCARO M and HESSEN S (1992) The Effects of Type I Antiarrhythmic Drugs on the Signal-Averaged Electrocardiogram in Patients with Malignant Ventricular Arrhythmias, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1992.tb02917.x, 15:10, (1445-1453), Online publication date: 1-Oct-1992. Delpón E, Valenzuela C, Pérez O and Tamargo J (2012) Electrophysiological effects of CRE-1087 in guinea-pig ventricular muscles, British Journal of Pharmacology, 10.1111/j.1476-5381.1992.tb12776.x, 107:2, (515-520), Online publication date: 1-Oct-1992. Campbell T (1992) Subclassification of Class I antiarrhythmic drugs: Enhanced relevance after CAST, Cardiovascular Drugs and Therapy, 10.1007/BF00055611, 6:5, (519-528), Online publication date: 1-Oct-1992. Harrison D and Bottorff M (1992) Advances in Antiarrhythmic Drug Therapy , 10.1016/S1054-3589(08)60966-7, (179-225), . Shirayama T, Inoue D, Inoue M, Miyazaki H, Tatsumi T, Asayama J, Katsume H and Nakagawa M (1992) Slow Kinetic Property of Mexiletine in Guinea Pig Atrium, Pharmacology & Toxicology, 10.1111/j.1600-0773.1992.tb00450.x, 70:3, (168-172), Online publication date: 1-Mar-1992. Weirich J (1992) Frequency-dependent action of antiarrhythmic drugs: The useful concept of periodical ligand binding, Basic Research in Cardiology, 10.1007/BF00804330, 87:3, (205-214), . Ranger S, Talajic M, Lemery R, Roy D, Villemaire C and Nattel S (1991) Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans., Circulation, 83:6, (1987-1994), Online publication date: 1-Jun-1991.Funck-Brentano C, Kibleur Y, Le Coz F, Poirier J, Mallet A and Jaillon P (1991) Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans., Circulation, 83:2, (536-545), Online publication date: 1-Feb-1991. Freedman R and Steinberg J (1991) Selective prolongation of QRS late potentials by sodium channel blocking antiarrhythmic drugs: Relation to slowing of ventricular tachycardia, Journal of the American College of Cardiology, 10.1016/0735-1097(91)90824-S, 17:5, (1017-1025), Online publication date: 1-Apr-1991. Bjørnstad H, Tande P and Refsum H (1991) Class III antiarrhythmic action of d-sotalol during hypothermia, American Heart Journal, 10.1016/0002-8703(91)90149-C, 121:5, (1429-1436), Online publication date: 1-May-1991. Delpón E, Valenzuela C and Tamargo J (2012) Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres, British Journal of Pharmacology, 10.1111/j.1476-5381.1991.tb09803.x, 103:2, (1411-1416), Online publication date: 1-Jun-1991. Hondeghem L and Snyders D (1990) Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence., Circulation, 81:2, (686-690), Online publication date: 1-Feb-1990.Talajic M, Papadatos D, Villemaire C, Nayebpour M and Nattel S (1990) Antiarrhythmic actions of diltiazem during experimental atrioventricular reentrant tachycardias. Importance of use-dependent calcium channel-blocking properties., Circulation, 81:1, (334-342), Online publication date: 1-Jan-1990.Anderson K, Walker R, Lux R, Ershler P, Menlove R, Williams M, Krall R and Moddrelle D (1990) Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart., Circulation, 81:3, (1024-1038), Online publication date: 1-Mar-1990.Anno T and Hondeghem L (1990) Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery., Circulation Research, 66:3, (789-803), Online publication date: 1-Mar-1990. Takanaka C and Singh B (1990) Barucainide, a novel class Ib antiarrhythmic agent with a slow kinetic property: Electrophysiologic observations in isolated canine and rabbit cardiac muscle, American Heart Journal, 10.1016/S0002-8703(05)80234-0, 119:5, (1050-1060), Online publication date: 1-May-1990. Arrowsmith J and Cross P (1990) Chapter 9. Antiarrhythmic Agents , 10.1016/S0065-7743(08)61585-7, (79-88), . Campbell T and Hemsworth P (1990) SELECTIVE DEPRESSION OF MAXIMUM RATE OF DEPOLARIZATION OF GUINEA-PIG VENTRICULAR ACTION POTENTIALS BY AMIODARONE AND LIGNOCAINE IN SIMULATED ISCHAEMIA: COMPARISON WITH ENCAINIDE, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.1990.tb01296.x, 17:2, (135-145), Online publication date: 1-Feb-1990. JORDAENS L, TAVERNIER R, VANMEERHAEGHE X, ROBBENS E and CLEMENT D (1990) Combination of Flecainide and Mexiletine for the Treatment of Ventricular Tachyarrhythmias, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1990.tb02170.x, 13:9, (1127-1135), Online publication date: 1-Sep-1990. Griffith M, Linker N, Garratt C, Ward D and Camm A (1990) Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia, The Lancet, 10.1016/0140-6736(90)92158-E, 336:8716, (670-673), Online publication date: 1-Sep-1990. Franz M, Chin M, Sharkey H, Griffin J and Scheinman M (1990) A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo, Journal of the American College of Cardiology, 10.1016/S0735-1097(10)80336-5, 16:4, (878-886), Online publication date: 1-Oct-1990. Colatsky T and Follmer C (1990) Potassium channels as targets for antiarrhythmic drug action, Drug Development Research, 10.1002/ddr.430190204, 19:2, (129-140), . Hasegawa J, Hirai S, Noguchi N, Hisatome I, Kotake H and Mashiba H (2012) Use-dependent effects of pirmenol on and conduction in guinea-pig ventricular myocardium, British Journal of Pharmacology, 10.1111/j.1476-5381.1990.tb13012.x, 99:4, (815-819), Online publication date: 1-Apr-1990. Gilliam F, Starmer C and Grant A (1989) Blockade of rabbit atrial sodium channels by lidocaine. Characterization of continuous and frequency-dependent blocking., Circulation Research, 65:3, (723-739), Online publication date: 1-Sep-1989.Anderson K, Walker R, Dustman T, Lux R, Ershler P, Kates R and Urie P (1989) Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo., Circulation, 79:4, (948-958), Online publication date: 1-Apr-1989.Nattel S and Jing W (1989) Rate-dependent changes in intraventricular conduction produced by procainamide in anesthetized dogs. A quantitative analysis based on the relation between phase 0 inward current and conduction velocity., Circulation Research, 65:6, (1485-1498), Online publication date: 1-Dec-1989. Surawicz B (1989) Ventricular arrhythmias: Why is it so difficult to find a pharmacologic cure?, Journal of the American College of Cardiology, 10.1016/0735-1097(89)90374-4, 14:6, (1401-1416), Online publication date: 1-Nov-1989. Frumin H, Kerin N and Rubenfire M (2013) Classification of Antiarrhythmic Drugs, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1989.tb03350.x, 29:5, (387-394), Online publication date: 1-May-1989. Franz M and Costard A (1988) Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ., Circulation, 77:5, (1177-1184), Online publication date: 1-May-1988.Bennett P, Woosley R and Hondeghem L (1988) Competition between lidocaine and one of its metabolites, glycylxylidide, for cardiac sodium channels., Circulation, 78:3, (692-700), Online publication date: 1-Sep-1988. ROSEN M and SPINELLI W (1988) Some Recent Concepts Concerning the Mechanisms of Action of Antiarrhythmic Drugs, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1988.tb04999.x, 11:10, (1485-1498), Online publication date: 1-Oct-1988. Kohlhardt M and Fichtner H (1988) Block of single cardiac Na+ channels by antiarrhythmic drugs: The effect of amiodarone, propafenone and diprafenone, The Journal of Membrane Biology, 10.1007/BF01870449, 102:2, (105-119), Online publication date: 1-May-1988. Vagos M, van Herck I, Sundnes J, Arevalo H, Edwards A and Koivumäki J (2018) Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges, Frontiers in Physiology, 10.3389/fphys.2018.01221, 9 (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, Europace, 10.1093/europace/euv319, (euv319) Van de Sande D, Kopljar I, Teisman A, Gallacher D, Snyders D, Lu H and Labro A (2019) Pharmacological Profile of the Sodium Current in Human Stem Cell-Derived Cardiomyocytes Compares to Heterologous Nav1.5+β1 Model, Frontiers in Pharmacology, 10.3389/fphar.2019.01374, 10 March 1, 1987Vol 75, Issue 3 Advertisement Article InformationMetrics Copyright © 1987 by American Heart Associationhttps://doi.org/10.1161/01.CIR.75.3.514 Originally publishedMarch 1, 1987 PDF download Advertisement
Referência(s)